USFDA nod to Takeda TAKHZYRO to prevent Hereditary Angioedema attacks in children 2 years of age and older Ruchika Sharma4 Feb 2023 1:15 PM ISTHereditary angioedema (HAE) is a rare genetic disorder that results in recurring attacks of edema - swelling - in various parts of the body, including...
Hereditary angioedema medicine: Takeda Biopharma launches CINRYZE in India Ruchika Sharma14 Dec 2022 12:06 PM ISTHereditary Angioedema (HAE) is a rare genetic condition that causes swelling in different parts of the body like limbs, face, abdomen, and larynx .
MSN Laboratories gets CDSCO panel nod to manufacture, market Icatibant Injection Dr. Divya Colin18 Nov 2022 6:00 PM ISTNew Delhi: Directing that the drug should be sold by retail under the prescription of the designated medical specialist only, the Subject Expert...
CDSCO Panel Tells MSN Lab to Produce Raw Data on Icatibant Injection Dr. Divya Colin24 Oct 2022 1:15 PM ISTNew Delhi: In response to drug maker MSN Laboratories' justification for bioavailability (BE) study waiver for Icatibant Injection 30mg/3ml (10mg/ml)...
Garadacimab efficacious prophylactic for patients with hereditary angioedema Dr. Shravani Dali15 April 2022 9:45 AM ISTGaradacimab is efficacious, subcutaneous prophylaxis in patients with hereditary angioedema (HAE-C1-INH), according to a recent study published in...
Donidalorsen significantly lowers rate of angioedema attacks in hereditary angioedema patients: NEJM Medical Dialogues Editorial Team30 March 2022 9:00 AM ISTUSA: Donidalorsen therapy resulted in a considerably reduced risk of angioedema attacks than placebo in patients with hereditary angioedema, says an...
Berotralstat reduces overall disease burden in hereditary angioedema: Study Medical Dialogues Editorial Team8 March 2022 9:00 AM ISTUSA: In a new study conducted by Emel Aygoren-Pursun and team, it was found that berotralstat, regardless of baseline attack rate, is an effective...
FDA Approves Berotralstat for Hereditary Angioedema prophylaxis MD Bureau4 Dec 2020 6:30 PM ISTThe US Food and Drug Administration has approved oral, once-daily ORLADEYOâ„¢ (berotralstat) for prophylaxis to prevent attacks of hereditary angioedema...
Cipla gets USFDA nod to generic version of Firazyr Ruchika Sharma14 July 2020 11:52 AM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
